Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Res ; 835(2): 213-23, 1999 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-10415376

RESUMO

Astrocytes and microglial cells were examined for expression of two immunologically important molecules, major histocompatibility complex class II (MHC-II) and nitric oxide (NO) following treatment with IFN-gamma and beta-amyloid (betaA) peptides, betaA(1-42) and betaA(25-35). IFN-gamma is a potent inducer of both MHC-II gene expression and NO production. The induction of MHC-II was inhibited by both betaA peptides in astrocytes but they had little or no effect in microglia. betaA peptides had no effect on NO release in astrocytes but on microglia betaA(1-42) synergistically induced NO release with IFN-gamma. Transient transfection of astrocytes with 5' deletional mutants of MHC-II IAalpha promoter linked to the chloramphenicol acetyl transferase reporter gene (IAalpha-CAT), demonstrated that betaA acts at the transcriptional level to downregulate IFN-gamma induced MHC-II gene expression in astrocytes. In previous studies, the induction of MHC-II on glial cells were suggested to be involved in the pathogenesis of neurodegenerative diseases and MHC-II(+) microglial cells were observed at much higher frequency than astrocytes. This study provides information on the regulation of the MHC-II gene expression in astrocytes and in microglial cells by betaA and this pathway may be critically involved in the immune/inflammatory regulation within the central nervous system.


Assuntos
Peptídeos beta-Amiloides/farmacologia , Astrócitos/efeitos dos fármacos , Regulação da Expressão Gênica/fisiologia , Genes MHC da Classe II , Microglia/efeitos dos fármacos , Óxido Nítrico/metabolismo , Animais , Astrócitos/metabolismo , Células Cultivadas , Regulação para Baixo , Interferon gama/farmacologia , Microglia/metabolismo , Regiões Promotoras Genéticas , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa
2.
Br J Pharmacol ; 121(5): 947-54, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9222552

RESUMO

1. KAR-2 (3"-(beta-chloroethyl)-2",4"-dioxo-3,5"-spiro-oxazolidino- 4-deacetoxy-vinblastine), is a bis-indol derivative; catharantine is coupled with the vindoline moiety which contains a substituted oxazolidino group. Our binding studies showed that KAR-2 exhibited high affinity for bovine purified brain tubulin (Kd-3 microM) and it inhibited microtubule assembly at a concentration of 10 nM. 2. Anti-microtubular activity of KAR-2 was highly dependent on the ultrastructure of microtubules: while the single tubules were sensitive, the tubules cross-linked by phosphofructokinase (ATP: D-fructose-6-phosphate-1-phosphotransferase, EC 2.7.1.11) exhibited significant resistance against KAR-2. 3. The cytoplasmic microtubules of Chinese hamster ovary mammalian and Sf9 insect cells were damaged by 1 microgram ml-1 KAR-2, as observed by indirect immunofluorescence and transmission electron microscopy. Scanning electron microscopy revealed intensive surface blebbing on both types of cells in the presence of KAR-2. 4. KAR-2 was effective in the mouse leukaemia P338 test in vivo without significant toxicity. Studies on a primary cerebro-cortical culture of rat brain and differentiated PC12 cells indicated that the toxicity of KAR-2 was significantly lower than that of vinblastine. The additional property of KAR-2 that distinguishes it from bis-indol derivatives is the lack of anti-calmodulin activity.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Tubulina (Proteína)/efeitos dos fármacos , Vimblastina/análogos & derivados , Animais , Células CHO , Calmodulina/antagonistas & inibidores , Bovinos , Cricetinae , Ensaios de Seleção de Medicamentos Antitumorais , Imuno-Histoquímica , Insetos , Leucemia P388/tratamento farmacológico , Camundongos , Microscopia Eletrônica , Ligação Proteica , Ratos , Tubulina (Proteína)/ultraestrutura , Células Tumorais Cultivadas , Vimblastina/farmacologia , Vincristina/farmacologia
4.
Eur J Pharmacol ; 270(4): 375-8, 1994 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-7805789

RESUMO

The influence of serum amyloid P component (SAP) on the survival of rat cerebrocortical cultures was tested. Cytotoxic cell death was examined on 8-9-day-old cell cultures by phase contrast microscopy and quantified by the measurement of lactate dehydrogenase (LDH) leakage. SAP (16-48 nM) evoked a concentration-dependent cell death within 24 h exposure. Our results suggest that SAP, as a constituent of cerebral amyloid deposits, may play a role in the pathomechanism of Alzheimer's disease.


Assuntos
Córtex Cerebral/citologia , Neurônios/efeitos dos fármacos , Componente Amiloide P Sérico/toxicidade , Animais , Morte Celular/efeitos dos fármacos , Células Cultivadas , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/enzimologia , Humanos , Isoenzimas , L-Lactato Desidrogenase/metabolismo , Neurônios/enzimologia , Ratos , Ratos Wistar , Componente Amiloide P Sérico/metabolismo
5.
J Chromatogr ; 578(1): 130-3, 1992 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-1400779

RESUMO

A rapid and reproducible method to isolate serum amyloid P component from healthy human plasma has been developed. It uses affinity chromatography on an agarose column followed by anion-exchange chromatography. It was found that the isolated compound has a significantly different isoelectric point (pI 5.7) from that reported previously (pI 4.1). The new data are in good agreement with calculated values determined from the amino acid composition of the protein.


Assuntos
Componente Amiloide P Sérico/isolamento & purificação , Cromatografia de Afinidade , Cromatografia por Troca Iônica , Humanos , Ponto Isoelétrico , Peso Molecular , Componente Amiloide P Sérico/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...